Top News Stories
Core and Group Health
Rising diabetes rates drive pharma opportunities as GLP-1s shake up treatment
By Kristen SmithbergGlobal prevalence climbs, boosting demand for insulin, devices and new therapies like Mounjaro and Ozempic.
Global prevalence climbs, boosting demand for insulin, devices and new therapies like Mounjaro and Ozempic.